연구성과로 돌아가기
2022 연구성과별 연구자 정보 (966 / 2879)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Tamura, Takao | Tamura, T | 15 | Kindai Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Tamura, Takao | Tamura, T | 15 | Kindai Univ, Dept Med Oncol, Nara Hosp, Ikoma, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Lee, Keun-Wook | Lee, KW | 16 | Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Oncol,Bundang Hosp, Seongnam, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Hamamoto, Yasuo | Hamamoto, Y | 17 | Keio Univ, Keio Canc Ctr, Sch Med, Tokyo, Japan | AAA-9941-2022 | Hamamoto, Yasuo | 0000-0002-5737-122X | Hamamoto, Yasuo | ykkang@amc.seoul.kr; | |
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kim, Jong Gwang | Kim, JG | 18 | Kyungpook Natl Univ, Sch Med, Daegu, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chin, Keisho | Chin, K | 19 | Japanese Fdn Canc Res, Dept Gastroenterol, Canc Inst Hosp, Tokyo, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Oh, Do-Youn | Oh, DY | 20 | Seoul Natl Univ, Grad Sch, Integrated Major Innovat Med Sci, Coll Med,Canc Res Inst,Seoul Natl Univ Hosp, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Minashi, Keiko | Minashi, K | 21 | Chiba Canc Ctr, Dept Clin Trial Promot, Chiba, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Cho, Jae Yong | Cho, JY | 22 | Yonsei Univ, Gangnam Severance Hosp, Dept Med Oncol, Coll Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Tsuda, Masahiro | Tsuda, M | 23 | Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Sameshima, Hiroki | Sameshima, H | 24 | Ono Pharmaceut Co Ltd, Med Affairs, Osaka, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chen, Li-Tzong | Chen, LT | 25 | Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chen, Li-Tzong | Chen, LT | 25 | Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Boku, Narikazu | Boku, N | 26 | Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan | ykkang@amc.seoul.kr; | |||||
| Exploring consumers' attitude formation toward their own brands when in crisis: cross-national comparisons between USA and China | Kim, Sojung | Kim, S | 1 | 교신저자 | Kyungpook Natl Univ, Dept Journalism & Mass Commun, Daegu, South Korea | sojungkim@knu.ac.kr;mark_yim@uml.edu; |
페이지 이동: